Stoke Therapeutics Inc (STOK)
11.49
+0.22
(+1.95%)
USD |
NASDAQ |
Jan 03, 16:00
11.49
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Enterprise Value: 369.39M for Jan. 3, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ADMA Biologics Inc | 4.374B |
| NovaBay Pharmaceuticals Inc | 2.298M |
| Palatin Technologies Inc | 24.40M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -11.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.43M |
| Revenue (Quarterly) | 4.894M |
| Total Expenses (Quarterly) | 34.90M |
| EPS Diluted (Quarterly) | -0.47 |
| Profit Margin (Quarterly) | -540.0% |
| Earnings Yield | -18.28% |
| Normalized Earnings Yield | -18.28 |